Testing effectiveness (Phase 2)Study completedNCT04790409
What this trial is testing
Sintilimab Combined With Anlotinib in Advanced NSCLC With EGFR Uncommon Mutations
Who this might be right for
Lung Cancer
Zhejiang Cancer Hospital 21
Showing 20 of 0 results